China Digest: B.H. Med, CHOWSING in funding news 2021-05-25T10:21:15-04:00May 25th, 2021| share this article! Chinese cancer therapy startup B.H. Med has closed $78.1 million in a Series C round led by Alibaba’s Jack Ma-backed PE firm Yunfeng Capital. Read More share this article! Related Posts Japan, EU universities to partner on fostering chip and AI talent May 3rd, 2024 Vietnam’s Galaxy Education eyes up to $20m fundraising to expand footprint May 3rd, 2024 Sony looks to boost film assets with $26bn Paramount acquisition May 3rd, 2024 Soundwill pushes to revalue Causeway Bay site as demand declines May 3rd, 2024
